Gaboxadol - Investigational Agent for the Treatment of Sleep Disorders
Key Data:
Drug (brand/generic)
Gaboxadol
Company/licensee
Lundbeck / Merck & Co
Therapy class
GABAA agonist
Product description
Direct-acting GABAA agonist that interacts directly with the GABA receptor site
Current indication
Treatment of insomnia
Market sector
CNS
Development status
Phase III
